- Home
- ICCC vs MASK Comparison
ICCC vs MASK Comparison
Compare ICCC & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- MASK
- Stock Information
- Founded
- ICCC 1982
- MASK 2017
- Country
- ICCC United States
- MASK China
- Employees
- ICCC N/A
- MASK N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- MASK
- Sector
- ICCC Health Care
- MASK
- Exchange
- ICCC Nasdaq
- MASK NYSE
- Market Cap
- ICCC 39.2M
- MASK 31.7M
- IPO Year
- ICCC 1987
- MASK 2025
- Fundamental
- Price
- ICCC $5.02
- MASK $2.77
- Analyst Decision
- ICCC
- MASK
- Analyst Count
- ICCC 0
- MASK 0
- Target Price
- ICCC N/A
- MASK N/A
- AVG Volume (30 Days)
- ICCC 4.1K
- MASK 44.2K
- Earning Date
- ICCC 02-25-2025
- MASK 01-01-0001
- Dividend Yield
- ICCC N/A
- MASK N/A
- EPS Growth
- ICCC N/A
- MASK 55.43
- EPS
- ICCC N/A
- MASK 0.15
- Revenue
- ICCC $23,838,001.00
- MASK $4,561,963.00
- Revenue This Year
- ICCC N/A
- MASK N/A
- Revenue Next Year
- ICCC N/A
- MASK N/A
- P/E Ratio
- ICCC N/A
- MASK $17.89
- Revenue Growth
- ICCC 46.37
- MASK 172.95
- 52 Week Low
- ICCC $3.34
- MASK $2.50
- 52 Week High
- ICCC $5.82
- MASK $3.99
- Technical
- Relative Strength Index (RSI)
- ICCC 47.31
- MASK N/A
- Support Level
- ICCC $4.84
- MASK N/A
- Resistance Level
- ICCC $5.25
- MASK N/A
- Average True Range (ATR)
- ICCC 0.27
- MASK 0.00
- MACD
- ICCC -0.04
- MASK 0.00
- Stochastic Oscillator
- ICCC 27.27
- MASK 0.00
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.